Three-dimensional cultures (or “organoids”) derived from the tumors of cancer patients closely replicate key properties of the original tumors, reveals a study published May 7 in Cell. These “organoid” cultures are amenable to large-scale drug screens for the detection of genetic changes associated with drug sensitivity and pave the way for personalized treatment approaches that could optimize clinical outcomes in cancer patients.
“This is the first time that a collection of cancer organoids, or a living biobank, has been derived from patient tumors,” says senior study author Mathew Garnett, a geneticist at the Wellcome Trust Sanger Institute. “We believe that these organoids are an important new tool in the arsenal of cancer biologists and may ultimately improve our ability to develop more effective cancer treatments.”
To study the causes of cancer and develop new cancer treatments, many laboratories use experimental model systems such as cells grown from patient tumors. However, currently available cell lines have been derived under suboptimal conditions and therefore fail to reflect important features of tumor cells. As a result, it has been challenging to predict the drug sensitivity of individual patients based on their unique spectrum of genetic mutations.
In recent years, scientists have developed organoid cell culture systems as an alternative approach to grow normal and diseased tissue in a dish. In contrast to cell lines, organoids display the hallmarks of the original tissue in terms of its 3D architecture, the cell types present, and their self-renewal properties. Given the advantages of organoids, Garnett and Hans Clevers of the Hubrecht Institute set out to test whether these cultures could potentially bridge the gap between cancer genetics and patient outcomes.
In the new study, the researchers grew 22 organoids derived from tumor tissue from 20 patients with colorectal cancer and then sequenced genomic DNA isolated from these cultures. The genetic mutations in the organoid cultures closely matched those in the corresponding tumor biopsies and agreed well with previous large-scale analyses of colorectal cancer mutations. These findings confirm that the cultures faithfully capture the genomic features of the tumors from which they are derived as well as much of the genomic diversity associated with colorectal cancer.
To link drug sensitivity to genetic changes, the researchers next screened the responses of the organoids to 83 experimental and approved cancer drugs. Given their diverse genetic profiles, the organoids displayed a range of sensitivities to the drugs. In validation of the approach, the researchers identified previously reported associations between specific mutations and resistance to particular drugs. The organoids also revealed a novel gene-drug association, indicating that the subset of cancer patients with RNF43 mutations would strongly benefit from a drug that inhibits a protein called porcupine. “At some point in the future, this approach may be suitable for modeling individual patient response to cancer therapies to inform clinical treatment,” Garnett says.
Read more:Â 3-D ‘organoids’ grown from patient tumors could personalize drug screening
The Latest on: Organoids
[google_news title=”” keyword=”Organoids” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Organoids
- Scientists discover a new signaling pathway and design a novel drug for liver fibrosison April 26, 2024 at 9:25 am
A healthy liver filters all the blood in your body, breaks down toxins and digests fats. It produces collagen to repair damaged cells when the liver is injured. However, a liver can produce too much ...
- Hybrid brain lets one species' neurons help out another'son April 25, 2024 at 9:53 pm
Adding rat stem cells to a mouse embryo resulted in a ‘hybrid brain’ in which the rat cells stepped in to restore function when the mouse’s sense of smell was removed, new research has shown. It’s the ...
- Party animal or wallflower? UC San Diego lab thinks autism-gene drug could help some thriveon April 25, 2024 at 12:13 pm
Scientist says genes they’re working with could also explain why wolves evolved into dogs, and why there are no chimp cities.
- With hybrid brains, these mice smell like a raton April 25, 2024 at 10:37 am
Mice lacking an olfactory system have had their sense of smell restored with neurons from rats, the first time scientists have successfully integrated the sensory apparatus of one species into another ...
- Lab-made miniorgans take scientists a step closer to curing canceron April 25, 2024 at 8:34 am
In the fight to cure cancer, scientists need better models. And they might just get them — human-derived organoids — thanks to light.
- How cleaning product chemicals called ‘quats’ may affect the brainon April 25, 2024 at 4:05 am
A common ingredient in household disinfectants called ‘quats’ may kill some brain cells, according to new research.
- Daily briefing: How an unlikely friendship with Jung influenced Pauli’s physicson April 24, 2024 at 5:00 pm
A patient-analyst relationship to psychoanalyst Carl Jung that evolved into a friendship deeply influenced physicist Wolfgang Pauli’s work. Plus, organoids shed light on cancer and other diseases, and ...
- A genetic patch corrects a rare syndrome in human brain organoid grafted into a raton April 24, 2024 at 9:51 am
The team led by Sergiu Pasca, from Stanford University, wants to test this promising strategy in children with Timothy Syndrome, which is associated with autism and epilepsy ...
- Brain organoids target rare neurological disorderon April 24, 2024 at 8:00 am
Scientists have devised a potential therapy for a rare neurological disease using brain tissue derived from human stem cells, raising hopes that so-called organoid technology can target other ...
- Opinion: It’s time to stop product and science testing on animalson April 24, 2024 at 3:44 am
Science has given us many marvels. Electricity immediately springs to mind, as does the telephone. The remarkable ease with which we’re able to trace our ancestry is utterly astounding, and ...
via Bing News